Purchase Agreement dated as of August 3, 2005



 Exhibit 10.1 
  
 Execution Version 
  
 PURCHASE AGREEMENT 
  
 THIS PURCHASE AGREEMENT (“Agreement”) is made as of the 3rd day of August, 2005 by and among Central European Distribution Corporation, a
Delaware corporation (the “Company”), and the Investors listed on Schedule I attached hereto (each an “Investor” and collectively the “Investors”). 
  
 In consideration of the mutual promises made herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  
 1. Definitions. In addition to those terms defined above and elsewhere in this Agreement, for the purposes of this Agreement, the following terms shall have the meanings set forth below: 
  
 “Affiliate” means, with respect to any Person, any other
Person which directly or indirectly through one or more intermediaries Controls, is controlled by, or is under common control with, such Person. 
  
 “Agents” means Avondale Partners, LLC, ING Bank N.V. (London Branch) and ING Financial Markets LLC. 
  
 “Bialystok Acquisition” means the acquisition by the Company
of 61% of the outstanding share capital of Polmos Bialystok S.A. pursuant to that certain Share Purchase Agreement, dated as of July 11, 2005, by and among the State Treasury of Poland, Carey Agri International Poland Sp. z o.o., and the
Company. 
  
 “Business Day” means a day, other
than a Saturday or Sunday, on which banks in New York City are open for the general transaction of business. 
  
 “Commission” means the U.S. Securities and Exchange Commission. 
  
 “Common Stock” means the Company’s common stock, par value $0.01 per share. 
  
 “Knowledge” means the actual knowledge of William V. Carey
or Chris Biedermann, after reasonable inquiry. 
  
 “Confidential Information” means trade secrets, confidential information and know-how (including but not limited to ideas, formulae, compositions, processes, procedures and techniques, research and development information,
computer program code, performance specifications, support documentation, drawings, specifications, designs, business and marketing plans, and customer and supplier lists and related information). 
  
 “Control” (including the terms “controlling”,
“controlled by” or “under common control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting
securities, by contract or otherwise. 







 “Escrow Agent” means Wachovia Bank, National Association. 
  
 “Escrow Agreement” means that certain Escrow Agreement,
dated as of the date hereof, by and among the Company, the Investors and the Escrow Agent. 
  
 “Intellectual Property” means all of the following: (i) patents, patent applications, patent disclosures and inventions (whether or not patentable and whether or not reduced to practice);
(ii) trademarks, service marks, trade dress, trade names, corporate names, logos, slogans and Internet domain names, together with all goodwill associated with each of the foregoing; (iii) copyrights and copyrightable works;
(iv) registrations, applications and renewals for any of the foregoing; and (v) proprietary computer software (including but not limited to data, data bases and documentation). 
  
 “Material Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of
operations, condition (financial and otherwise) and business of the Company and its Subsidiaries taken as a whole, or (ii) the ability of the Company to perform its obligations under the Transaction Documents. 
  
 “Person” means an individual, corporation, partnership,
limited liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 
  
 “Registration Rights Agreement” means that certain
Registration Rights Agreement, in the form attached hereto as Exhibit A, pursuant to which the Company will agree to provide certain registration rights under the 1933 Act and applicable state securities laws. 
  
 “SEC Filings” has the meaning set forth in Section 4.6.

  
 “Shares” means the shares of Common Stock
being purchased by the Investors hereunder. 
  
 “Subsidiary” has the meaning set forth in Section 4.1. 
  
 “Transaction Documents” means this Agreement, the Escrow Agreement and the Registration Rights Agreement. 
  
 “1933 Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder.

  
 “1934 Act” means the Securities Exchange Act
of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder. 
  
 2. Purchase and Sale of the Shares; Escrow. 
  
 2.1 Purchase and Sale of the Shares. Subject to the terms and conditions of this Agreement, on the Closing Date, (a) each of the Investors
hereby severally, and not jointly, agrees to purchase that number of Shares listed opposite such Investor’s name on Schedule I, and (b) the Company hereby agrees to sell and issue to the Investors an aggregate of 3,360,000 Shares. The per
share purchase price of the Shares to by paid by the Investors under this Agreement shall be $34.69 (the “Per Share Purchase Price”). The aggregate purchase price for the Shares to be paid by all Investors under this Agreement shall be
referred to as the “Purchase Price.” 
  

 2 








 2.2 Escrow. Contemporaneously with the execution and delivery of this Agreement, the Company, each
Investor and the Escrow Agent have executed and delivered the Escrow Agreement. Within one (1) Business Day of the date of this Agreement, each Investor will cause a wire transfer in same day funds to be sent to the account of the Escrow Agent
in the amount set forth opposite such Investor’s name on Schedule I. 
  
 3. Closing. Upon confirmation that the conditions to Closing specified herein have been satisfied or duly waived by the Investors and the Company, as applicable, prior to the termination of this Agreement
pursuant to Section 6.3 below, (a) the Company shall deliver to the Escrow Agent a notice that the Purchase Price being held pursuant to the Escrow Agreement shall be released to the Company, with any interest that has accrued under the
Escrow Agreement to be delivered to the Investors pro rata, (b) the Company shall deliver to the Agents, in trust, a certificate or certificates, registered in such name or names as the Investors may designate, representing the Shares, with
instructions that such certificates are to be held for release to the Investors only upon receipt by the Company of the Purchase Price pursuant to the terms of the Escrow Agreement. On the date (the “Closing Date”) the Company receives the
Purchase Price, the certificates evidencing the Shares shall be released to the Investors (the “Closing”). The Closing of the purchase and sale of the Shares shall take place at the offices of Dickstein Shapiro Morin & Oshinsky
LLP, 1177 Avenue of the Americas, New York, N.Y. 10036, or at such other location and on such other date as the Company and the Investors shall mutually agree. 
  

4. Representations and Warranties of the Company. The Company hereby represents and warrants to the Investors that, except as set forth in the
SEC Filings (as defined below): 
  
 4.1 Organization, Good
Standing and Qualification. Each of the Company and its Subsidiaries is a corporation duly organized and validly existing under the laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to carry on its
business as now conducted and to own its properties. Each of the Company and its Subsidiaries is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the conduct of its business or its
ownership or leasing of property makes such qualification or leasing necessary unless the failure to so qualify has not and could not reasonably be expected to have a Material Adverse Effect. The Company’s subsidiaries (the
“Subsidiaries”) are reflected in the SEC Filings. 
  
 4.2 Authorization. The Company has full power and authority and has taken all requisite action on the part of the Company, its officers, directors and stockholders necessary for (i) the authorization, execution and delivery of
the Transaction Documents, (ii) authorization of the performance of all obligations of the Company hereunder or thereunder, and (iii) the authorization, issuance and delivery of the Shares. The Transaction Documents constitute the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to
or affecting creditors’ rights generally, and subject to general equitable principles. The issuance of the Shares does not require the approval of the Company’s stockholders pursuant to the Company’s Bylaws, Certificate of
Incorporation, the provisions of the Delaware General Corporation Law, Nasdaq Marketplace Rule 4350(i) or any other similar rules or regulations promulgated under other trading markets or securities exchanges that are applicable to the Company, or
otherwise. 
  
 4.3 Capitalization. The SEC Filings set
forth (a) the authorized capital stock of the Company on the date hereof; (b) the number of shares of capital stock issued and outstanding; (c) the number of shares of capital stock issuable pursuant to the Company’s stock plans;
and (d) the number of shares of capital stock issuable and reserved for issuance pursuant to securities exercisable for, or 

  

 3 








 
convertible into or exchangeable for any shares of capital stock of the Company. All of the issued and outstanding shares of the Company’s capital stock
have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights and were issued in full compliance with applicable state and federal securities law and any rights of third parties. All of the issued and
outstanding shares of capital stock of each Subsidiary have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights, were issued in full compliance with applicable state and federal securities law and
any rights of third parties and are owned by the Company, beneficially and of record, subject to no lien, encumbrance or other adverse claim. No Person is entitled to preemptive or similar statutory or contractual rights with respect to any
securities of the Company. Except as set forth in the SEC Filings, there are no outstanding warrants, options, convertible securities or other rights, agreements or arrangements of any character under which the Company or any of its Subsidiaries is
or may be obligated to issue any equity securities of any kind and except as contemplated by this Agreement, neither the Company nor any of its Subsidiaries is currently in negotiations for the issuance of any equity securities of any kind. There
are no voting agreements, buy-sell agreements, option or right of first purchase agreements or other similar agreements of any kind among the Company and any of the securityholders of the Company relating to the securities of the Company held by
them. Except for the Registration Rights Agreement, no Person has the right to require the Company to register any securities of the Company under the 1933 Act, whether on a demand basis or in connection with the registration of securities of the
Company for its own account or for the account of any other Person. 
  
 The issuance and sale of the Shares will not obligate the Company to issue shares of Common Stock or other securities to any other Person (other than the Investors) and will not result in the adjustment of the exercise, conversion, exchange
or reset price of any outstanding security. 
  
 The Company does
not have outstanding stockholder purchase rights or “poison pill” or any similar arrangement in effect giving any Person the right to purchase any equity interest in the Company upon the occurrence of certain events. 
  
 4.4 Valid Issuance. The Company has reserved a sufficient number of
shares of Common Stock for the issuance of the Shares pursuant to this Agreement. The Shares have been duly and validly authorized and, when issued and paid for pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and
shall be free and clear of all encumbrances and restrictions (other than those created by the Investors), except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws. 
  
 4.5 Consents. The execution, delivery and performance by the Company
of the Transaction Documents and the offer, issuance and sale of the Shares require no consent of, action by or in respect of, or filing with, any Person, governmental body, agency, or official, including without limitation, any trading market or
securities exchange, other than the following: (a) filings, if any, pursuant to applicable state and federal securities laws which the Company undertakes to file within the applicable time periods, (b) the filing with the Commission of one
or more registration statements in accordance with the requirements of the Registration Rights Agreement, and (c) the filing of a listing application for the listing of the Shares with the Trading Market (as defined below), which shall be done
pursuant to the rules of the Trading Market. Subject to the accuracy of the representations and warranties of each Investor set forth in Section 5 hereof, the Company has taken all action necessary to exempt (i) the issuance and sale of
the Shares, and (ii) the other transactions contemplated by the Transaction Documents from the provisions of any stockholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination or control share law
or statute binding on the Company or to which the Company or any of its assets and properties may be subject and any provision of the Company’s Certificate of Incorporation or Bylaws that is or could reasonably be expected to become applicable
to the Investors as a result of the transactions contemplated hereby, including, without limitation, the issuance of the Shares and the ownership, disposition or voting of the Shares by the Investors or the exercise of any right granted to the
Investors pursuant to this Agreement or the other Transaction Documents. 
  

 4 








 4.6 SEC Filings; Financial Statements. 
  
 (a) The Company has filed all reports required to be filed by it under the
1934 Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law to file such material) (the foregoing materials, including the exhibits
thereto (together with any materials filed by the Company under the 1934 Act, whether or not required), being collectively referred to herein as the “SEC Filings,” except that solely for purposes of this Section 4.6(a), “SEC
Filings” shall not be deemed to include any Current Reports on Form 8-K (or amendments thereto) that are “furnished” by the Company to the Commission solely to comply with Regulation F-D promulgated under the 1934 Act) on a timely
basis or has timely filed a valid extension of time of filing and has filed any such SEC Filings prior to the expiration of any such extension. As of their respective dates, the SEC Filings complied in all material respects with the requirements of
the 1934 Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Filings, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
  
 (b) The financial statements of the Company included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004,
Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2005 and SEC Filings filed subsequent to the filing of such filings comply in all material respects with applicable accounting requirements and the rules and regulations of
the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved
(“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the
financial position of the Company and its consolidated Subsidiaries as of the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. Except as set forth in the most recent financial
statements of the Company included in the SEC Filings filed prior to the date hereof, neither the Company nor any Subsidiary has incurred any liabilities, contingent or otherwise, except those incurred in the ordinary course of business, consistent
(as to amount in nature) with past practices since the date of such financial statements, none of which, individually or in the aggregate, have had or could reasonably be expected to have a Material Adverse Effect. All material agreements to which
the Company and its Subsidiaries are a party or to which any of their respective property or assets are subject that are required to be filed as exhibits to the SEC Filings under Item 601 of Regulation S-K are included as a part of, or
specifically identified in, the SEC Filings. 
  
 4.7
Business. The Company and its Subsidiaries are engaged only in the business described in the SEC Filings, and the SEC Filings contain a complete and accurate description of the business of the Company and its Subsidiaries, taken as a whole.

  
 4.8 Use of Proceeds. The net proceeds of the sale of
the Shares hereunder shall be used by the Company to finance a portion of the purchase price for the Bialystok Acquisition. 
  
 4.9 No Material Adverse Change. Since December 31, 2004, except as identified and described in the SEC Filings, there has not been:

  
 (i) any change in the consolidated assets, liabilities,
financial condition or operating results of the Company from that reflected in the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, except for changes in the ordinary course of
business which have not and could not reasonably be expected to have a Material Adverse Effect, individually or in the aggregate; 
  

 5 








 (ii) any declaration or payment of any dividend, or any authorization or payment of any distribution, on
any of the capital stock of the Company, or any redemption or repurchase of any securities of the Company; 
  
 (iii) any material damage, destruction or loss, whether or not covered by insurance to any material assets or properties of the Company or its
Subsidiaries; 
  
 (iv) any waiver, not in the ordinary course of
business, by the Company or any Subsidiary of a material right or of a material debt owed to it; 
  
 (v) any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by the Company or a Subsidiary, except in the ordinary
course of business and which is not material to the assets, properties, financial condition, operating results or business of the Company and its Subsidiaries taken as a whole (as such business is presently conducted and as it is proposed to be
conducted); 
  
 (vi) any change or amendment to the
Company’s Certificate of Incorporation or Bylaws, or material change to any material contract or arrangement by which the Company or any Subsidiary is bound or to which any of their respective assets or properties is subject, except for changes
in the ordinary course of business which have not and could not reasonably be expected to have a Material Adverse Effect, individually or in the aggregate; 
  
 (vii) any material labor difficulties or labor union organizing activities with respect to employees of the Company or any Subsidiary; 
  
 (viii) any transaction entered into by the Company or a Subsidiary other
than in the ordinary course of business; 
  
 (ix) the loss of the
services of any key employee, or material change in the composition or duties of the senior management of the Company or any Subsidiary; or 
  
 (x) the loss or threatened loss of any supplier or customer which has had or could reasonably be expected to have a Material Adverse Effect. 

 
 4.10 No Conflict, Breach, Violation or Default. The execution,
delivery and performance of the Transaction Documents by the Company and the issuance and sale of the Shares will not conflict with or result in a breach or violation of any of the terms and provisions of, or constitute a default under (i) the
Company’s Certificate of Incorporation or the Company’s Bylaws, both as in effect on the date hereof, or (ii)(a) any statute, rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having
jurisdiction over the Company, any Subsidiary or any of their respective assets or properties, or (b) any agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or a Subsidiary is bound or to which any
of their respective assets or properties is subject, except, in the case of clause (ii) above, for such conflicts, breaches, violations or defaults as could not reasonably be expected to have a Material Adverse Effect. 
  

 6 








 4.11 Tax Matters. The Company and each Subsidiary have timely prepared and filed all tax returns
required to have been filed by the Company or such Subsidiary with all appropriate governmental agencies and timely paid all taxes shown thereon or otherwise owed by it, except those being contested in good faith. The charges, accruals and reserves
on the books of the Company in respect of taxes for all fiscal periods are adequate in all material respects, and there are no material unpaid assessments against the Company or any Subsidiary nor, to the Company’s Knowledge, any basis for the
assessment of any additional taxes, penalties or interest for any fiscal period or audits by any federal, state or local taxing authority except for any assessment which is not material to the Company and its Subsidiaries, taken as a whole. All
taxes and other assessments and levies that the Company or any Subsidiary is required to withhold or to collect for payment have been duly withheld and collected and paid to the proper governmental entity or third party when due. There are no tax
liens or claims pending or, to the Company’s Knowledge, threatened against the Company or any Subsidiary or any of their respective assets or property. There are no outstanding tax sharing agreements or other such arrangements between the
Company and any Subsidiary or other corporation or entity. 
  
 4.12 Certificates, Authorities and Permits. The Company and each Subsidiary possess adequate certificates, authorities or permits issued by appropriate governmental agencies or bodies necessary to conduct the business now operated by
it, and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, authority or permit that, if determined adversely to the Company or such Subsidiary, could
reasonably be expected to have a Material Adverse Effect, individually or in the aggregate. 
  
 4.13 No Labor Disputes. No material labor dispute with the employees of the Company or any Subsidiary exists or, to the Company’s Knowledge, is threatened. 
  
 4.14 Intellectual Property. The Company owns or possesses sufficient
rights to use all Intellectual Property free and clear of any material liens, security interests, charges, encumbrances, equities and other adverse claim, which is necessary to conduct its businesses as currently conducted and as presently
contemplated to be conducted. The Company has not received any written notice of, nor has Knowledge of, any infringement of or conflict with asserted rights of others with respect to any Intellectual Property, and to the Company’s Knowledge,
the present activities of the Company and the Subsidiaries do not infringe any patent, copyright, trademark, trade name, or other proprietary rights of any third party. 
  
 4.15 Environmental Matters. Neither the Company nor any Subsidiary (a) is in violation of any statute, rule,
regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human
exposure to hazardous or toxic substances (collectively, “Environmental Laws”), (b) owns or operates any real property contaminated with any substance that is subject to any Environmental Laws, (c) is liable for any off-site
disposal or contamination pursuant to any Environmental Laws, or (d) is subject to any claim relating to any Environmental Laws, which violation, contamination, liability or claim has had or could reasonably be expected to have a Material
Adverse Effect, individually or in the aggregate, and there is no pending or, to the Company’s Knowledge, threatened, investigation that might lead to such a claim. 
  
 4.16 Litigation. There are no pending actions, suits, inquiries, notices of violations, investigations, or
proceedings (collectively, an “Action”) against the Company, its Subsidiaries or any of its or their properties, and, to the Company’s Knowledge, no such Action is threatened or contemplated, which Action, if determined adversely to
the Company, its Subsidiaries or any of its or their properties, as 

  

 7 








 
the case may be, would have or could reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or
officer thereof in their capacity as such, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the
Company’s Knowledge, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. 
  
 4.17 Compliance. 
  
 (a) Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, could result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any agreement, credit
facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or
affected (whether or not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body, or (iii) is or has been in violation of any statute, rule or regulation of any
governmental authority, including without limitation, all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety, and employment and labor matters, except in
each case as did not or would not (as applicable), individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
  
 (b) The Company is in compliance with the applicable requirements of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder
by the Commission, except where such noncompliance would not have or reasonably be expected to result in a Material Adverse Effect. 
  
 4.18 Insurance Coverage. The Company and each Subsidiary maintains in full force and effect insurance coverage against such liabilities, claims and
risks and in such amounts as is customary for comparably situated companies for the business being conducted and properties owned or leased by the Company and each Subsidiary. 
  
 4.19 Brokers and Finders. Other than fees paid to the Agents, no brokerage or finder’s fees or commissions are
or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this Agreement. The Investors shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by this Agreement. 

 
 4.20 No General Solicitation or General Advertising. Neither the
Company nor any Person acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D under the 1933 Act) in connection with the offer or sale of any of the Shares. 
  
 4.21 No Integrated Offering. Neither the Company nor any of its
Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances that would adversely affect reliance by the
Company on Section 4(2) for the exemption from registration for the transactions contemplated hereby or would require registration of the Shares under the 1933 Act. 
  

 8 








 4.22 Private Placement; State Securities Laws. Subject in part to the accuracy of the
representations and warranties of the Investors contained in Section 5, the offer and sale of the Shares to the Investors as contemplated hereby is exempt from the registration requirements of the 1933 Act. On or before the Closing Date, if
required, the Company shall take all necessary action to qualify, or to obtain, an exemption for the Shares under such securities laws of each state as shall be necessary to qualify, or to obtain an exemption from, the sale of the Shares.

  
 4.23 Transactions with Affiliates. Except as disclosed
in the SEC Filings, none of the officers or directors of the Company and, to the Company’s Knowledge, none of the employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than as holders of
stock options and/or warrants, and for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any officer, director or such employee or, to the Company’s Knowledge, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee or partner. 
  
 4.24 Accounting System; Controls and
Procedures. The Company makes and keeps accurate books and records and maintains a system of accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or
specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets; (iii) access to assets
is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company has established and maintains disclosure controls and procedures (as defined in 1934 Act Rules 13a-15(e) and 15d-15(e)), which (i) are designed to ensure that material information relating to the Company, including
its consolidated subsidiaries, is made known to the Company’s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the 1934
Act are being prepared; (ii) have been evaluated for effectiveness as of the end of the period covered by the Company’s most recent annual or quarterly report with the Commission which precedes the date of this Agreement; and
(iii) are effective in all material respects to perform the functions for which they were established. Based on the most recent evaluation of its disclosure controls and procedures, as of the date hereof, the Company is not aware of
(i) any significant deficiencies or material weaknesses in the design or operation of internal control over financial reporting (as defined in 1934 Act Rules 13a-15(f) and 15d-15(f)) which are reasonably likely to adversely affect the
Company’s ability to record, process, summarize and report financial information or (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control
over financial reporting. The Company is not aware of any change in its internal control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting. 
  
 4.25
No Price Stabilization or Manipulation; Compliance with Regulation M. The Company has not taken directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the
price of the shares of the Common Stock or any other “Reference Security” (as defined in Rule 100 of Regulation M under the 1934 Act (“Regulation M”)) to facilitate the sale or resale of the Shares, and has taken no action which
would directly or indirectly violate Regulation M. 
  
 4.26
Investment Company. The Company is not, and after giving effect to the sale of the Shares and the application of the net proceeds therefrom, will not be, an “investment company” within the meaning of the Investment Company Act of
1940, as amended, or an Affiliate of an “investment company.” 
  

 9 








 4.27 Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries, nor, to the
Company’s Knowledge, any of their respective current or former directors, officers, employees, agents or other Person acting on behalf of the Company or any of its Subsidiaries, have (i) directly or indirectly, used any corporate funds for
unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any direct or indirect unlawful payments to any governmental officials or employees from corporate funds,
(iii) failed to disclose fully any contribution made by the Company or made by any Person acting on its behalf and of which the Company is aware in violation of law; (iv) established or maintained any unlawful or unrecorded fund of
corporate monies or other assets; (v) made any false or fictitious entries on the books and records of the Company or any Subsidiary; (vi) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of
any nature; or (vii) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended. 
  
 5. Representations and Warranties of the Investors. Each of the Investors hereby severally, and not jointly, represents and warrants to the Company
and each other Investor that: 
  
 5.1 Organization and
Existence. The Investor is a validly existing corporation, limited partnership or limited liability company and has all requisite corporate, partnership or limited liability company power and authority to invest in the Shares pursuant to this
Agreement. Such Investor (if not an individual) has not been formed for the specific purpose of acquiring the Shares. Such Investor has provided the Company with its jurisdiction of organization and its principal place of business. 
  
 5.2 Authorization; Non-contravention. The execution, delivery and
performance by the Investor of the Transaction Documents to which such Investor is a party have been duly authorized and will each constitute the valid and legally binding obligation of the Investor, enforceable against the Investor in accordance
with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally, and subject to general equitable
principles. 
  
 5.3 Purchase Entirely for Own Account. The
Shares to be received by the Investor hereunder will be acquired for the Investor’s own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of the 1933 Act, and the Investor has
no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the 1933 Act. Such Investor does not have any agreement or understanding, whether or not legally binding, direct or indirect, with any
other Person to sell or otherwise distribute the Shares. The Investor is not a broker dealer registered with the Commission under the 1934 Act or an entity engaged in a business that would require it to be so registered. 
  
 5.4 Investment Experience. The Investor acknowledges that it can bear
the economic risk and complete loss of its investment in the Shares and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment contemplated hereby. Such Investor
understands that the purchase of the Shares involves substantial risk. 
  
 5.5 Disclosure of Information. The Investor has had an opportunity to receive all additional information related to the Company requested by it and to ask questions of and receive answers from the Company regarding the terms and
conditions of the issuance and sale of the Shares and the business, properties, prospects and financial condition of the Company and to obtain any additional 

  

 10 








 
information requested and has received and considered all information such Investor deems relevant to make an informed decision to purchase the Shares. The
Investor acknowledges that the Company has made copies of the SEC Filings available to such Investor. Neither such inquiries nor any other due diligence investigation conducted by the Investor shall modify, amend or affect the Investor’s right
to rely on the Company’s representations and warranties contained in this Agreement. The Investor has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its
acquisition of the Shares. 
  
 5.6 Restricted Securities.
The Investor understands that the Shares are characterized as “restricted securities” under the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that
under such laws and applicable regulations such securities may be resold without registration under the 1933 Act only in certain limited circumstances. The Investor understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Shares.

  
 5.7 Legends. The Investor understands that, except as
provided below and until such time as the resale of the Shares have been registered under the 1933 Act as contemplated by the Registration Rights Agreement, certificates evidencing the Shares shall bear the following or any similar legend:

  
 (a) “THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OFFERED FOR SALE, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION FROM COUNSEL IN A FORM ACCEPTABLE TO THE COMPANY AND ITS LEGAL COUNSEL STATING THAT SUCH REGISTRATION IS NOT REQUIRED.” 
  
 (b) If required by the authorities of any state in connection with the
issuance of sale of the Shares, the legend required by such state authority. 
  
 5.8 Accredited Investor. The Investor is an accredited investor as defined in Rule 501(a) of Regulation D, as amended, under the 1933 Act. 
  
 5.9 No General Solicitation. The Investor did not learn of the investment in the Shares by means of any form of
general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including (i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media,
or broadcast over television or radio, or (ii) any seminar or meeting to which such Investor was invited by any of the foregoing means of communications. 
  

5.10 Brokers and Finders. Except for the fees payable to the Agents, for which the Company is solely responsible, no Person will have, as a
result of the transactions contemplated by the Transaction Documents, any valid right, interest or claim against or upon the Company, any Subsidiary or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Investor. 
  

 11 








 5.11 Prohibited Transactions. 
  
 (a) Since the date each Investor entered into a confidentiality agreement with the Agents or the Company and prior to the
date of this Agreement, no Investor has, directly or indirectly, effected or agreed to effect any short sale, whether or not against the box, established any “put equivalent position” (as defined in Rule 16a-1(h) under the 1934 Act) with
respect to the Common Stock, granted any other right (including, without limitation, any put or call option) with respect to the Common Stock or with respect to any security that includes, relates to or derived any significant part of its value from
the Common Stock or otherwise sought to hedge its position in the Shares. 
  
 (b) The Investor is aware of the following Telephone Interpretation in the SEC Manual of Publicly Available Telephone Interpretations (July 1997): 
  
 A.65. Section 5 
  
 An issuer filed a Form S-3 registration statement for a secondary offering of common stock which is not yet effective. One of the selling shareholders
wanted to do a short sale of common stock “against the box” and cover the short sale with registered shares after the effective date. The issuer was advised that the short sale could not be made before the registration statement becomes
effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would, therefore, be a violation of Section 5 if the shares were effectively sold prior to the effective date. 
  
 5.12 Reliance on Exemptions. The Investor understands that the Shares
are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such
Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Investor set forth herein in order to determine the availability of such exemptions and the eligibility of such to acquire the
Shares. 
  
 6. Conditions to Closing; Termination.

  
 6.1 Conditions to the Investors’ Obligations. The
obligation of the Investors to purchase the Shares at the Closing is subject to the fulfillment to the Investors’ satisfaction, on or prior to the Closing Date, of the following conditions, any of which may be waived by an Investor (as to
itself only): 
  
 (a) The representations and warranties made by
the Company in Section 4 hereof qualified as to materiality shall be true and correct in all respects on the Closing Date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such
representation or warranty shall be true and correct as of such earlier date, and the representations and warranties made by the Company in Section 4 hereof not qualified as to materiality shall be true and correct in all material respects on
the Closing Date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of such earlier date. The Company
shall have performed in all material respects all obligations and conditions herein required to be performed or observed by it on or prior to the Closing Date. 
  

 12 








 (b) The Company shall have obtained any and all consents, permits, approvals, registrations and waivers
necessary for consummation of the purchase and sale of the Shares and the consummation of the other transactions contemplated by the Transaction Documents, all of which shall be in full force and effect. 
  
 (c) The Company shall have executed and delivered the Registration Rights
Agreement. 
  
 (d) No judgment, writ, order, injunction, award or
decree of or by any court, or judge, justice or magistrate, including any bankruptcy court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have been instituted by any governmental
authority, enjoining or preventing the consummation of the transactions contemplated hereby or in the other Transaction Documents. 
  
 (e) The Company shall have delivered a Certificate, executed on behalf of the Company by its Chief Executive Officer or its Chief Financial Officer,
dated as of the Closing Date, certifying to the fulfillment of the conditions specified in subsections (a), (h) and (j) of this Section 6.1. 
  
 (f) The Company shall have delivered a Certificate, executed on behalf of the Company by its Secretary, dated as of the Closing Date, certifying the
resolutions adopted by the Board of Directors of the Company approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Shares, certifying the current versions of the Certificate of
Incorporation and Bylaws of the Company and certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on behalf of the Company. 
  
 (g) The Investors shall have received opinions from the Company’s legal counsel, dated as of the Closing Date, in form
and substance reasonably acceptable to the Investors and addressing such legal matters as the Investors may reasonably request. 
  
 (h) No stop order or suspension of trading shall have been imposed by the Commission or any other governmental or regulatory body with respect to public
trading in the Common Stock. 
  
 (i) No statute, rule,
regulation, executive order, decree, ruling, injunction, action, proceeding or interpretation shall have been enacted, entered, promulgated, endorsed or adopted by any court or governmental authority of competent jurisdiction or any self-regulatory
organization or trading market or the staff of any of the foregoing, having authority over the matters contemplated hereby which questions the validity of, or challenges or prohibits the consummation of, any of the transactions contemplated by this
Agreement. 
  
 (j) All conditions to the obligation of the
Company to consummate the Bialystok Acquisition shall have been fulfilled to the Company’s satisfaction, and contemporaneous with the Closing the Company shall consummate the Bialystok Acquisition. 
  
 (k) William V. Carey, Evangelos Evangelou and Chris Biedermann shall have
executed and delivered the Lock-up Agreement in the form attached hereto as Exhibit B. 
  

 13 








 6.2 Conditions to Obligations of the Company. The Company’s obligation to sell and issue the
Shares at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company: 
  
 (a) The representations and warranties made by the Investors in
Section 5 hereof, other than the representations and warranties contained in Sections 5.3, 5.4, 5.5, 5.6, 5.7, 5.8 and 5.9 (the “Investment Representations”), shall be true and correct in all material respects when made, and shall be
true and correct in all material respects on the Closing Date with the same force and effect as if they had been made on and as of said date. The Investment Representations shall be true and correct in all respects when made, and shall be true and
correct in all respects on the Closing Date with the same force and effect as if they had been made on and as of said date. The Investors shall have performed in all material respects all obligations and conditions herein required to be performed or
observed by them on or prior to the Closing Date. 
  
 (b) The
Investors shall have executed and delivered the Registration Rights Agreement. 
  
 (c) No statute, rule, regulation, executive order, decree, ruling, injunction, action, proceeding or interpretation shall have been enacted, entered, promulgated, endorsed or adopted by any court or governmental
authority of competent jurisdiction or any self-regulatory organization or trading market or the staff of any of the foregoing, having authority over the matters contemplated hereby which questions the validity of, or challenges or prohibits the
consummation of, any of the transactions contemplated by this Agreement 
  
 (d) All conditions to the obligation of the Company to consummate the Bialystok Acquisition shall have been fulfilled to the Company’s satisfaction and contemporaneous with the Closing the Company shall
consummate the Bialystok Acquisition. 
  
 (e) Each of the Agents
shall have executed and delivered a Placement Agent Certificate in the form attached hereto as Exhibit C. 
  
 6.3 Termination of Obligations to Effect Closing; Effects. 
  
 (a) The obligations of the Company, on the one hand, and the Investors, on the other hand, to effect the Closing shall
terminate as follows: 
  
 (i) Upon the mutual written consent of
the Company and the Investors; 
  
 (ii) By the Company if any of
the conditions set forth in Section 6.2 shall have become incapable of fulfillment, and shall not have been waived by the Company; 
  
 (iii) By an Investor (with respect to itself only) if any of the conditions set forth in Section 6.1 shall have become incapable of fulfillment, and
shall not have been waived by the Investor; or 
  
 (iv) Unless
waived pursuant to Section 9.6 of this Agreement, if the Closing has not occurred on or prior to November 30, 2005; 
  

 14 








 provided, however, that, except in the case of clauses (ii) and (iii) above, the party seeking to terminate its
obligation to effect the Closing shall not then be in breach of any of its representations, warranties, covenants or agreements contained in this Agreement or the other Transaction Documents if such breach has resulted in the circumstances giving
rise to such party’s seeking to terminate its obligation to effect the Closing. 
  
 (b) In the event of termination by the Company or any Investor of its obligations to effect the Closing pursuant to this Section 6.3, written notice thereof shall forthwith be given to the other Investors and the
other Investors shall have the right to terminate their obligations to effect the Closing upon written notice to the Company and the other Investors. Nothing in this Section 6.3 shall be deemed to release any party from any liability for any
breach by such party of the terms and provisions of this Agreement or the other Transaction Documents. 
  
 7. Covenants and Agreements of the Company. 
  
 7.1 Listing of Underlying Shares and Related Matters. The Company hereby agrees, promptly following the Closing of the transactions contemplated by
this Agreement, to cause the Shares to be listed on the Nasdaq National Market or such other securities exchange or trading market in which the Company’s Common Stock is listed or quoted (the “Trading Market”). For so long as the
Investors beneficially own any of the Shares, the Company will use its best efforts to continue the listing and trading of its Common Stock on the Trading Market and will comply in all respects with the Company’s reporting, filing and other
obligations under the bylaws or rules of such Trading Market to ensure the continued eligibility for trading of the Shares thereon. 
  
 7.2 Removal of Legends. Upon the earlier of (i) registration for resale pursuant to the Registration Rights Agreement and receipt by the
Company of the Investor’s written confirmation that such Shares will not be disposed of except in compliance with the prospectus delivery requirements of the 1933 Act or (ii) Rule 144(k) becoming available the Company shall, upon an
Investor’s written request, promptly cause certificates evidencing the Investor’s Shares to be replaced with certificates which do not bear such restrictive legends. 
  
 7.3 Lock-Up Agreement. Without the prior written consent of the Agents (which consent may be withheld at the sole
discretion of the Agents) and other than as contemplated by this Agreement or the Registration Rights Agreement with respect to the Shares, during the period commencing on the date hereof and continuing to and including the later of (i) the
90th day following the Closing Date or (ii) the effectiveness of the registration statement to be filed by the Company pursuant to the Registration Rights Agreement (the “Lock-Up Period”), the Company will not, directly or indirectly,
sell, offer, contract or grant any option to sell (including without limitation any short sale), pledge, transfer, establish an open “put equivalent position” within the meaning of Rule 16a-1(h) under the 1934 Act, give, donate or
otherwise dispose of, directly or indirectly, or announce the offering of, or file any registration statement under the 1933 Act in respect of, any shares of Common Stock, options or warrants to acquire shares of Common Stock, or securities
exchangeable or exercisable for or convertible into shares of Common Stock, or publicly announce an intention to do any of the foregoing; provided, however, that the Company may (i) issue shares of its Common Stock or options to purchase its
Common Stock, or shares of Common Stock upon exercise of options, pursuant to any stock option, stock bonus or other stock plan or compensatory arrangement duly approved by the Board of Directors of the Company, (ii) issue shares of its Common
Stock pursuant to the acquisition of another entity by the Company by merger, purchase of all or substantially all of the assets, or otherwise; provided, that the fair market value (as determined in good faith by the Board of Directors of the
Company) of such shares issued in connection with each such acquisition (other than the issuance of shares pursuant to that certain Share 

  

 15 








 
Sale Agreement, dated as of June 27, 2005, between Remy Cointreau S.A., Botapol Management B.V., Takirra Investment Corporation N.V., Carey Agri
International Poland Sp. z o.o. and the Company) does not exceed $10,000,000, (iii) issue shares of its capital stock upon conversion, exercise or exchange of any warrants, options, securities or other rights directly or indirectly convertible
into, or exercisable or exchangeable for, Common Stock, and (iv) issue securities in connection with a joint venture or development agreement or strategic partnership or similar agreement approved by the Board of Directors of the Company, the
primary purpose of which is not to raise equity capital; provided, that the fair market value (as determined in good faith by the Board of Directors of the Company) of such shares issued pursuant to this subsection (iv) does not exceed
$10,000,000, 
  
 8. Survival and Indemnification.

  
 8.1 Survival. The representations, warranties,
covenants and agreements contained in this Agreement shall survive the Closing of the transactions contemplated by this Agreement for a period of one (1) year after the Closing. 
  
 8.2 Indemnification. The Company agrees to indemnify and hold harmless each Investor and its Affiliates and their
respective directors, officers, employees and agents from and against any and all losses, claims, damages, liabilities and expenses (including without limitation reasonable attorney fees and disbursements and other expenses incurred in connection
with investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof) (collectively, “Losses”) to which such Person may become subject as a result of any breach of
representation, warranty, covenant or agreement made by or to be performed on the part of the Company under the Transaction Documents, and will reimburse any such Person for all such amounts as they are incurred by such Person. 
  
 8.3 Conduct of Indemnification Proceedings. Promptly
after receipt by any Person (the “Indemnified Person”) of notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity
may be sought pursuant to Section 8.2, such Indemnified Person shall promptly notify the Company in writing and the Company shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified
Person, and shall assume the payment of all fees and expenses; provided, however, that the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its obligations hereunder except to the extent that
the Company is materially prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such counsel; or (ii) in the reasonable judgment of counsel to such Indemnified Person representation of both parties by the same
counsel would be inappropriate due to actual or potential differing interests between them. The Company shall not be liable for any settlement of any proceeding effected without its written consent, which consent shall not be unreasonably withheld,
but if settled with such consent, or if there be a final judgment for the plaintiff, the Company shall indemnify and hold harmless such Indemnified Person from and against any loss or liability (to the extent stated above) by reason of such
settlement or judgment. Without the prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, the Company shall not effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Person from all liability arising out of such
proceeding. 
  

 16 








 9. Miscellaneous. 
  
 9.1 Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of
the Company and (i) prior to the Closing, the Investors purchasing at least 67% of the Shares pursuant to this Agreement and (ii) following the Closing, holders of at least a majority of the Shares then outstanding; provided, however, that
an Investor may assign its rights and delegate its duties hereunder in whole or in part to an Affiliate or to a third party, in each case acquiring some or all of its Shares in a private transaction without the prior written consent of the Company
or the other Investors; provided, that such transferee agrees in writing to be bound by the terms, provisions and conditions of this Agreement and the Transaction Documents, and such transfer is in compliance with all of the terms and provisions of
this Agreement and the Transaction Documents and permitted by federal and state securities laws; and, provided, further, that no such assignment or obligation shall affect the obligations of such Investor hereunder. The provisions of this Agreement
shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
  

9.2 Counterparts; Faxes. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. This Agreement may also be executed via facsimile, which shall be deemed an original. 
  
 9.3 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement. 
  
 9.4 Notices. Unless
otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described (i) if given by personal delivery, then such notice shall be deemed given upon
such delivery, (ii) if given by telex or telecopier or electronic mail, then such notice shall be deemed given upon receipt of confirmation of complete transmittal, (iii) if given by mail, then such notice shall be deemed given upon the
earlier of (A) receipt of such notice by the recipient or (B) three days after such notice is deposited in first class mail, postage prepaid, and (iv) if given by an internationally recognized overnight air courier, then such notice
shall be deemed given one business day after delivery to such carrier. All notices shall be addressed to the party to be notified at the address as follows, or at such other address as such party may designate by ten days’ advance written
notice to the other party: 
  
 If to the Company:

  
 Central European Distribution Corporation

 Two Bala Plaza 
 Suite 300 
 Bala Cynwyd, Pennsylvania 19004 
 Telephone: (610) 660-7817 
 Facsimile: (610) 667-3308 
 Attention: Chief Executive Officer 
  

 17 








 with a copy to: 
  
 Dickstein Shapiro Morin & Oshinsky LLP 
 1177 Avenue of the Americas 
 New York, New York 10036 
 Telephone: (212) 835-1412 
 Facsimile: (212) 997-9880 
 Attention: Malcolm I. Ross, Esq. 
  
 If to the Investors: 
  
 to the addresses set forth on Schedule I hereto. 
  
 9.5
Expenses. The parties hereto shall pay their own costs and expenses in connection herewith. In the event that legal proceedings are commenced by any party to this Agreement against another party to this Agreement in connection with this
Agreement or the other Transaction Documents, the party or parties which do not prevail in such proceedings shall severally, but not jointly, pay their pro rata share of the reasonable attorneys’ fees and other reasonable out-of-pocket costs
and expenses incurred by the prevailing party in such proceedings. 
  
 9.6 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with
the written consent of the Company and (i) prior to the Closing, the Investors purchasing at least 67% of the Shares pursuant to this Agreement and (ii) following the Closing, holders of at least a majority of the Shares then outstanding.
Any amendment or waiver effected in accordance with this paragraph shall be binding upon each holder of any Shares purchased under this Agreement at the time outstanding, each future holder of all such Shares, and the Company. 
  
 9.7 Publicity. Except as set forth below, no public release or
announcement concerning the transactions contemplated hereby shall be issued by the Company or the Investors without the prior written consent of the Company (in the case of a release or announcement by the Investors) or the Agents (in the case of a
release or announcement by the Company) (which consents shall not be unreasonably withheld), except as such release or announcement as the Company reasonably determines may be required by law or the applicable rules or regulations of any securities
exchange or securities market, in which case the Company or the Investors, as the case may be, shall allow the Agents or the Company, as applicable, to the extent reasonably practicable in the circumstances, reasonable time to comment on such
release or announcement in advance of such issuance. By 8:30 a.m. (New York City time) on the trading day immediately following the Closing Date, the Company shall issue a press release disclosing the consummation of the transactions contemplated by
this Agreement. No later than the fourth business day (as defined by the Commission) following the Closing Date, the Company will file a Current Report on Form 8-K attaching the press release described in the foregoing sentence as well as copies of
the Transaction Documents. In addition, the Company will make such other filings and notices in the manner and time required by the Commission. 
  

 18 








 9.8 Severability. Any provision of this Agreement that is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written so as to be enforceable to the
maximum extent permitted by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by applicable law, the
parties hereby waive any provision of law which renders any provision hereof prohibited or unenforceable in any respect. 
  
 9.9 Entire Agreement. This Agreement, including the Exhibits, and the other Transaction Documents constitute the entire agreement among the parties
hereof with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof and thereof. 
  
 9.10 Further Assurances. The parties shall execute and deliver all
such further instruments and documents and take all such other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 
  
 9.11 Governing Law; Consent to Jurisdiction; Waiver of Jury Trial.
This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of
the courts of the State of New York located in New York County and the United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and
the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this
Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of
venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. TO THE EXTENT PERMITTED BY
APPLICABLE LAW, EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
  
 9.12 Independent Nature of Investors’ Obligations and Rights. The
obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any
Transaction Document. The decision of each Investor to purchase Shares pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained herein or in any Transaction Document, and no action
taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a
group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that
no Investor will be acting as agent of such Investor in connection with monitoring its investment in the Shares or enforcing its rights under the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement or out of the other Transaction 

  

 19 








 
Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. The Company
acknowledges that each of the Investors has been provided with the same Transaction Documents for the purpose of closing a transaction with multiple Investors and not because it was required or requested to do so by any Investor. 
  
 [Signature Page Follows] 
  

 20 








 IN WITNESS WHEREOF, the parties have executed this Purchase Agreement or caused their duly authorized
officers to execute this Purchase Agreement as of the date first above written. 
  

			
	 INVESTORS:
  
 Strategic Advisors Corp. - on behalf of managed account


	Name of Entity
		
	By:	 	 /s/ Martin G. Braun


	Name:	 	Martin G. Braun
	Title:	 	President
	  
  
 Strategic Advisors Corp. - on behalf of managed account


	Name of Entity
		
	By:	 	 /s/ Martin G. Braun


	Name:	 	Martin G. Braun
	Title:	 	President
	  
  
 Epic Capital Management as Investment Manager


	Name of Entity
		
	By:	 	 /s/ David Fawcett


	Name:	 	David Fawcett
	Title:	 	CEO
	  
  
 Gluskin Sheff + Associates, Inc.


	Name of Entity
		
	By:	 	 /s/ Sylvia Cheung


	Name:	 	Sylvia Cheung
	Title:	 	VP, Investment Accounting
	  
  
 Castlerigg Master Investments Ltd.


	Name of Entity
		
	By:	 	 /s/ John Nusbaum


	Name:	 	John Nusbaum
	Title:	 	Senior Managing Director
	  
  
 Gardner Lewis


	Name of Entity
		
	By:	 	 /s/ William D. Zantzinger, Jr.


	Name:	 	William D. Zantzinger, Jr.
	Title:	 	Partner
	  
  
 Magna Global Emerging Markets Fund (Sub-Fund of Magna Umbrella Fund Pic)


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Magna Global Emerging Markets Fund (Sub-Fund of Magna Umbrella Fund Pic)
	  
  
 Magna Eastern European Fund (Sub-Fund of Magna Umbrella Fund Pic)


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Magna Eastern European Fund (Sub-Fund of Magna Umbrella Fund Pic)
	  
  
 Julius Bear Multistock - Central Europe Stock Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Julius Bear Multistock - Central Europe Stock Fund
	  
  
 US Global Accolade Funds - Eastern European Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of US Global Accolade Funds - Eastern European Fund
	  
  
 US Global Accolade Funds - Global Emerging Markets Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of US Global Accolade Funds - Global Emerging Markets Fund
	  
  
 Nouvelle Croissance Europe


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Nouvelle Croissance Europe
	  
  
 Manulife Global Fund - Emerging Eastern Europe Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Manulife Global Fund - Emerging Eastern Europe Fund
	  
  
 Charlemagne CIS Fund Limited


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of Charlemagne CIS Fund Limited
	  
  
 OCCO Eastern European Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of OCCO Eastern European Fund
	  
  
 OCCO Global Emerging Markets Fund


	Name of Entity
		
	By:	 	 /s/ Adrian Jones


	Name:	 	Adrian Jones
	Title:	 	Authorized Signatory for and on Behalf of OCCO Global Emerging Markets Fund










			
	 Elliot Associates LP


	 Name of Entity

		
	By:	 	 /s/ Elliot Greenberg


	Name:	 	Elliot Greenberg
	Title:	 	Elliot Greenberg, Vice President
	
	  
 Elliot International, LP


	 Name of Entity

		
	By:	 	 /s/ Elliot Greenberg


	Name:	 	Elliot Greenberg
	Title:	 	Elliot Greenberg, Vice President
	
	  
 Greenway Managed Account Series E


	 Name of Entity

		
	By:	 	 /s/ Randel Freeman


	Name:	 	Randel Freeman
	Title:	 	Authorized Signatory
	
	  
 Centaurus Alpha Master Fund LP


	 Name of Entity

		
	By:	 	 /s/ Randel Freeman


	Name:	 	Randel Freeman
	Title:	 	Authorized Signatory
	
	  
 Citi Centaurus Ltd


	 Name of Entity

		
	By:	 	 /s/ Randel Freeman


	Name:	 	Randel Freeman
	Title:	 	Authorized Signatory
	
	  
 Trellus Partners, LP, LP2, Offshore


	 Name of Entity

		
	By:	 	 /s/ Adam Lisden


	Name:	 	Adam Lisden
	Title:	 	President
	
	  
 Capital Ventures International, by Heights Capital
Management Inc. as Authorized Agent


	 Name of Entity

		
	By:	 	 /s/ Martin J. Kobinger


	Name:	 	Martin J. Kobinger
	Title:	 	Investment Manager
	
	  
 Perry Partners LP


	 Name of Entity

		
	By:	 	 /s/ Randall Borkenstein


	Name:	 	Randall Borkenstein
	Title:	 	Managing Director and Chief Financial Officer
	
	  
 Perry Commitment Master Fund, LP


	 Name of Entity

		
	By:	 	 /s/ Randall Borkenstein


	Name:	 	Randall Borkenstein
	Title:	 	Managing Director and Chief Financial Officer
	
	  
 Perry Commitment Fund, LP


	 Name of Entity

		
	By:	 	 /s/ Randall Borkenstein


	Name:	 	Randall Borkenstein
	Title:	 	Managing Director and Chief Financial Officer
	
	  
 Perry Partners, International, Inc.


	 Name of Entity

		
	By:	 	 /s/ Randall Borkenstein


	Name:	 	Randall Borkenstein
	Title:	 	Managing Director and Chief Financial Officer
	
	  
 Ascend Offshore Fund, Ltd.


	 Name of Entity

		
	By:	 	 /s/ Malcolm Fairbairn


	Name:	 	Malcolm Fairbairn
	Title:	 	Director
	
	  
 Ascend Offshore Leveraged Fund, Ltd.


	 Name of Entity

		
	By:	 	 /s/ Malcolm Fairbairn


	Name:	 	Malcolm Fairbairn
	Title:	 	Director
	
	  
 Ascend Partners Leveraged Fund, LP


	 Name of Entity

		
	By:	 	 /s/ Malcolm Fairbairn


	Name:	 	Malcolm Fairbairn
	Title:	 	Managing Member
	
	  
 Allen Investment Management LLC, F/B/O Allen Archon
LP


	 Name of Entity

		
	By:	 	 /s/ Rosemary Farelli


	Name:	 	Rosemary Farelli
	Title:	 	Secretary
	
	  
 Wells Capital Management


	 Name of Entity

		
	By:	 	 /s/ Mai S. Shiver


	Name:	 	Mai S. Shiver
	Title:	 	Director Business Risk


  
  
  







 IN WITNESS WHEREOF, the parties have executed this Purchase Agreement or caused their duly authorized
officers to execute this Purchase Agreement as of the date first above written. 
  

			
	CENTRAL EUROPEAN
	DISTRIBUTION CORPORATION
	 
		
	By:	 	 /s/ William V. Carey


	Name:	 	William V. Carey
	Title:	 	President and Chief Executive Officer


  
 Signature Page
to CEDC Purchase Agreement